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Chronic cigarette smoking is linked
with structural alterations in brain regions
showing acute nicotinic drug‑induced
functional modulations
Matthew T. Sutherland1* , Michael C. Riedel1,2, Jessica S. Flannery1, Julio A. Yanes3, Peter T. Fox4,5,6,
Elliot A. Stein7 and Angela R. Laird2

Abstract
Background: Whereas acute nicotine administration alters brain function which may, in turn, contribute to
enhanced attention and performance, chronic cigarette smoking is linked with regional brain atrophy and poorer
cognition. However, results from structural magnetic resonance imaging (MRI) studies comparing smokers versus
nonsmokers have been inconsistent and measures of gray matter possess limited ability to inform functional relations
or behavioral implications. The purpose of this study was to address these interpretational challenges through metaanalytic techniques in the service of clarifying the impact of chronic smoking on gray matter integrity and more fully
contextualizing such structural alterations.
Methods: We first conducted a coordinate-based meta-analysis of structural MRI studies to identify consistent structural alterations associated with chronic smoking. Subsequently, we conducted two additional meta-analytic assessments to enhance insight into potential functional and behavioral relations. Specifically, we performed a multimodal
meta-analytic assessment to test the structural–functional hypothesis that smoking-related structural alterations
overlapped those same regions showing acute nicotinic drug-induced functional modulations. Finally, we employed
database driven tools to identify pairs of structurally impacted regions that were also functionally related via metaanalytic connectivity modeling, and then delineated behavioral phenomena associated with such functional interactions via behavioral decoding.
Results: Across studies, smoking was associated with convergent structural decreases in the left insula, right cerebellum, parahippocampus, multiple prefrontal cortex (PFC) regions, and the thalamus. Indicating a structural–functional
relation, we observed that smoking-related gray matter decreases overlapped with the acute functional effects of
nicotinic agonist administration in the left insula, ventromedial PFC, and mediodorsal thalamus. Suggesting structuralbehavioral implications, we observed that the left insula’s task-based, functional interactions with multiple other
structurally impacted regions were linked with pain perception, the right cerebellum’s interactions with other regions
were associated with overt body movements, interactions between the parahippocampus and thalamus were linked
with memory processes, and interactions between medial PFC regions were associated with face processing.
Conclusions: Collectively, these findings emphasize brain regions (e.g., ventromedial PFC, insula, thalamus) critically
linked with cigarette smoking, suggest neuroimaging paradigms warranting additional consideration among smokers
(e.g., pain processing), and highlight regions in need of further elucidation in addiction (e.g., cerebellum).
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Background
Over the past two decades, neuroimaging has contributed
important insight into the structural and functional brain
alterations linked with drug abuse in general [1–3] and
nicotine addiction in particular [4–6]. For example, such
studies have revealed that nicotine administration alters
functional brain activity, inducing enhanced activity in
some regions involved with attention and cognition (e.g.,
thalamus, lateral frontoparietal cortices, anterior cingulate cortex [ACC]) yet reducing activity in other regions
involved with task-irrelevant mental operations (e.g.,
mind wandering; ventromedial prefrontal cortex, posterior cingulate cortex, parahippocampus) [6–8]. These
functional brain alterations may, in part, provide a neurobiological account of the well-documented cognitive
enhancing properties of acute nicotine administration [9,
10]. On the other hand, chronic cigarette smokers, compared with nonsmokers, exhibit poorer global cognition
and impaired performance on specific measures of working memory, cognitive flexibility, visuospatial learning and
memory, and processing speed [11–13]. Aligning with
such neurocognitive observations, structural magnetic
resonance imaging (MRI) studies have detected reduced
gray matter integrity among smokers in multiple discrete brain regions including the prefrontal cortex (PFC),
ACC, insula, thalamus, and cerebellum [e.g., 14–17]. Such
regional atrophy may result from the deleterious impact
of cigarette smoking and/or reflect predisposing neurobiological, neurocognitive, or personality factors.
However, structural MRI results among chronic smokers, to some degree, have been inconsistent. For example,
gray matter in the insula of smokers has been reported to
be decreased [15, 18, 19], increased [20], or comparable
to that among nonsmokers [17, 21]. Similarly, whereas
some studies have detected smoking-related structural
decreases in the ventromedial PFC [17, 19, 22] or thalamus [17, 21, 23], others have not [14, 21, 24]. Heterogeneous findings may be the product of cross-sectional
designs with modest-to-moderate sample sizes, betweenstudy variability in participant attributes (e.g., varying age
ranges, smoking histories, sex ratios, or other sociodemographic characteristics), and/or methodological differences in MRI acquisition or data analysis parameters
(e.g., smoothing, registration techniques, or normalization templates). Such issues constrain interpretations
from single studies and necessitate the post hoc integration of results from multiple independently conducted
studies to better estimate parameters of interest [25].

Accordingly, neuroimaging meta-analytic techniques
have been increasingly adopted to delineate spatially convergent results across studies, including identification of
consistently observed gray matter alterations among specific phenotypes [26–28].
Although useful for elucidating potential structural
alterations among smokers, measures of gray matter are
limited in their ability to inform interpretation of functional relations or behavioral implications. Regarding
structural–functional relations, a plausible hypothesis
is that brain regions showing chronic smoking-related
structural alterations overlap those same regions showing acute nicotinic drug-induced functional modulations.
One perspective is that the repeated impact of nicotine
exposure within discrete brain regions over an individual’s extended smoking history culminates in neuroadaptations that may manifest as gray matter perturbations
in those same regions. An alternative perspective is that
pre-existing structural alterations may render some individuals more susceptible to acute pharmacologic effects
and, in turn, to addiction. Regardless of the causative
pathway (or combination thereof ), integrating structural and functional neuroimaging results may provide
insight into the neurobiological processes potentially
contributing to the initiation, escalation, and/or maintenance of cigarette smoking. In other words, a multimodal perspective may allow for enhanced interpretation
of structural alterations [29, 30]. Regarding structuralbehavioral implications, a frequently posed question not
easily answered by considering morphometric outcomes
is: what are the behavioral consequences of structural
alterations in a particular brain region (or set of regions).
As opposed to conjectural discussion of behavioral relevance, empirical approaches to more fully contextualize gray matter alterations are of growing interest [e.g.,
31–33]. Such approaches provide an objective means to
support behavioral interpretations and/or suggest neuroimaging paradigms warranting additional consideration
among a particular phenotype.
In the current study, we aimed to address these interpretational challenges by employing established and
emergent meta-analytic techniques to clarify the impact
of cigarette smoking on gray matter integrity and to
more fully contextualize such morphometic alterations.
The specific goals of our study were threefold. First,
we sought to identify convergent structural alterations
across studies associated with chronic smoking via the
well-established, coordinate-based activation likelihood
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estimation (ALE) meta-analytic framework. We operationalized the effects of chronic smoking as gray matter alterations identified in studies utilizing smoker
versus nonsmoker comparisons. Second, we tested the
structural–functional hypothesis that chronic smoking-related gray matter alterations overlap those same
regions showing acute nicotinic drug-induced functional effects via a multimodal meta-analytic assessment.
Whereas we operationalized chronic effects as structural
alterations identified in smoker versus nonsmoker (i.e.,
between-subjects) comparisons, we operationalized the
acute effects of nicotinic acetylcholine receptor (nAChR)
agonist administration as functional alterations indentified in pharmacological neuroimaging studies, the vast
majority of which employed within-subjects (i.e., drug
versus control condition) comparisons. Third, we sought
to provide enhanced structural-behavioral insight via
emergent database driven meta-analytic tools, which
allow for the characterization of typical patterns of
task-based co-activation and associated behavioral phenomenon for user-specified seed regions of interest.
Specifically, using smoking-related gray matter alterations to define seed regions, we performed meta-analytic
connectivity modeling [33] and behavioral decoding
assessments [34, 35] on data archived in an extensive
neuroimaging repository (http://www.brainmap.org/) to
objectively support behavioral interpretations of structural alterations.

Methods
Structural MRI study search and selection

We performed an iterative literature search to compile structural neuroimaging studies interrogating gray
matter alterations among chronic cigarette smokers
compared with nonsmokers. In the first iteration, we
searched the Web of Science (http://www.webofknowledge.com) and PubMed (http://www.pubmed.gov) databases for peer-reviewed articles with the following logical
conjunction of terms: (“voxel-based morphometry” OR
“morphometry” OR “gray matter density” OR “gray matter volume”) AND (“nicotine” OR “tobacco” OR “cigarette” OR “smok*”). In a second iteration, we consulted
the bibliographies of recent review articles [5, 36] and
one existing meta-analysis [37] for studies potentially
not identified by the database queries. Although a previous meta-analysis has considered the structural impact
of chronic smoking, we note that several additional studies have emerged subsequent to that report and highlight
our emphasis on structural–functional and structuralbehavioral relations as a further distinguishing characteristic. In a final iteration, we tracked the references of and
citations to relevant papers, thereby compiling additional
studies.
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We included studies in this meta-analysis that: (1)
assessed gray matter using structural MRI, (2) reported
a set of coordinates (i.e., foci) from a between-subjects
contrast comparing smokers to matched nonsmoking
participants, (3) reported coordinates in a defined stereotaxic space (i.e., Talairach or Montreal Neurological
Institute [MNI]), (4) performed a whole-brain analysis,
and (5) provided sufficient information regarding characterization of smoking behaviors (e.g., pack-years, Fagerström Test of Nicotine Dependence [FTND] scores, years
smoking, number of cigarettes smoked per day), basic
demographics of the study samples (e.g., age, sex, N), and
data analysis strategies (e.g., smoothing parameters, statistical thresholds).
Accordingly, we identified 15 peer-reviewed articles
involving 761 cigarette smokers and 1182 nonsmokers
(Additional file 1: Figure S1; Table S1) [14, 15, 17–24,
38–42]. Across these 15 identified studies, the smoker
samples were on average 41.8 ± 16.2 (mean ± SD) years
of age and were composed of 40.9 ± 25.6 % females. At
the time of scanning, smokers reported cigarette use for
22.9 ± 17.0 years, smoked 17 ± 4.0 cigarettes per day,
and were moderately nicotine dependent as indicated
by FTND scores (4.5 ± 1.3 out of 10). These characteristics were rather consistent across studies and are generally representative of community-based samples of
smokers. The nonsmoker samples did not differ from
smokers in terms of age (41.1 ± 17.5 years; t[14] = −0.9,
p = 0.4) or sex (41.6 ± 25.0 % female: t[13]1 = 0.5,
p = 0.6). Most studies mitigated the influence of other
drug use by screening via interview and/or urine toxicology on scan days (11 of 15 studies; Additional file 1:
Table S2). For each study, we also tabulated information
on the type of MRI scanner used and data collection/
analysis parameters (Additional file 1: Table S2). All
included studies utilized significance thresholds corrected for multiple comparisons or uncorrected thresholds combined with a spatial extent criterion. These
studies distinguished gray matter alterations by the
nonsmoker > smoker (i.e., smoking-related decreases)
and smoker > nonsmoker directions (i.e., smokingrelated increases). Of those included, 14 studies (78
foci) reported gray matter decreases among smokers
and 5 studies (10 foci) reported increases. Given the
limited number of studies and recent arguments that
ALE meta-analyses based on less than 10 experiments/
studies run the risk of obtaining results driven by a single experiment as opposed to identifying convergence
across experiments [43], gray matter increases were not
considered further.
1

Paired sample t test. One study did not report the number of females/
males.
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Structural impact of chronic cigarette smoking:
meta‑analytic procedures

To identify areas of convergent gray matter decreases
across studies, we performed a coordinate-based metaanalysis using the revised version [44, 45] of the activation (in this application, Anatomic) likelihood estimation
(ALE) algorithm [26, 46] as implemented in GingerALE
v2.3.4 (http://www.brainmap.org/ale/). ALE is a voxelwise approach for combining neuroimaging results
across a collection of experiments/contrasts and thereby
identifying locations of statistically significant spatial
convergence. The ALE framework models foci as centers
of three-dimensional Gaussian probability distributions,
thus accounting for spatial uncertainty due to withinand between-study variability. Foci are weighted by study
sample size, where larger samples are associated with narrower distributions and smaller samples with wider distributions. We first linearly transformed foci reported in
MNI to Talairach space [47] and then generated modeled
maps of each individual contrast using their respective
foci (paralleling the modeled activation maps of functional MRI [fMRI] meta-analyses). Next, we calculated
a voxel-wise ALE score (i.e., the union of all contrasts’
modeled maps) quantifying the spatial convergence of
structural alterations across the brain. To identify clusters of statistically significant convergence, we compared
these obtained ALE scores with those from an empirical
null-distribution derived from a permutation procedure
[27]. This comparison resulted in nonparametric p value
maps, which we then thresholded at a cluster-corrected
level (pcorrected < 0.05; voxel-level: p < 0.005, cluster extent:
344 mm3) and exported to MANGO (http://www.ric.
uthscsa.edu/mango/) for visualization on an anatomical
(Talairach) template.
Conjoint chronic smoking‑related structural effects
and acute drug‑induced functional effects: multimodal
meta‑analytic procedures

We leveraged previous meta-analytic outcomes regarding the impact of acute nAChR agonist exposure on brain
function to enhance interpretation of structural alterations observed among chronic cigarette smokers. Specifically, in a previous meta-analysis [6] we identified 38
pharmacological fMRI studies that assessed the acute
functional effects of nAChR agonist administration (i.e.
pharmacologic administration or cigarette smoking) relative to a baseline condition (i.e., placebo administration
or smoking abstinence condition) across various cognitive and affective neuroimaging paradigms. The studies
meeting selection criteria in that functional meta-analysis involved 796 participants, reported 364 foci from 77
contrasts, and distinguished functional activity modulations by the baseline > drug (i.e., activity decrease) and
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drug > baseline (i.e., activity increase) directions. We
characterized the impact of nAChR agonists on brain
function using the ALE framework (paralleling that
described above) and separately identified brain regions
showing either convergent activity increases or decreases
using a cluster-level corrected threshold (pcorrected < 0.05).
To test the hypothesis that smoking-related gray matter decreases overlap those same regions showing acute
drug-induced effects, we conducted a multimodal metaanalytic assessment. Specifically, we performed a conjunction analysis to identify those brain regions, if any,
showing statistically significant convergence when considering both: (1) chronic smoking-related structural
effects (smokers versus nonsmokers), and (2) acute
drug-induced functional effects (nAChR agonist manipulation versus control condition). Employing a conservative minimum statistic conjunction [48], we identified
brain regions showing conjoint structural and functional
effects by computing the intersection of the two thresholded meta-analytic maps combined with an additional
overlap-cluster extent criterion (100 mm3).
Behavioral relevance of structurally impacted regions:
meta‑analytic connectivity modeling and behavioral
decoding

As gray matter assessments possess limited ability to
inform functional or behavioral interpretations, we
subsequently employed emergent meta-analytic tools
to more fully contextualize the brain circuit-level and
behavioral consequences of structural alterations identified among smokers [28, 49, 50]. Specifically, to determine whether structurally impacted brain regions reflect
disruption of functionally interrelated neurocircuits, we
utilized meta-analytic connectivity modeling (MACM),
a validated database driven approach for delineating
brain areas that co-activate with a seed region of interest
(ROI) across many neuroimaging tasks [33, 51, 52]. This
assessment was conducted using the BrainMap database
(http://www.brainmap.org/) which is an online repository of over 13,500 neuroimaging contrasts from ~2800
journal articles (as of January, 2016) archived as threedimensional coordinate-based results (x, y, z) as well as
relevant metadata describing the associated experimental design [53–55]. Whereas we utilized the database’s
archived activation coordinates to characterize the coactivation/connectional profile of structurally-identified
ROIs, we utilized the metadata to facilitate behavioral
interpretation of smoking-related structural alterations
via meta-analytic behavioral decoding. Although the
data utilized in these assessments were from healthy participants, they nonetheless offer a useful path to enhance
interpretation of observed structural alterations among
smokers. These analyses attempt to identify within a
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typical range of function whether pairs of regions interact and, if so, under what behavioral context. If two brain
regions are structurally impacted by a certain neuropsychiatric condition and those same regions also appear
to interact among healthy participants under a specific
behavioral context, one plausible inductive conclusion
is that the psychological processes associated with that
behavioral context may be disrupted in the neuropsychiatric condition.
Moving beyond isolated regions, we conducted a
MACM assessment to characterize the typical pattern
of task-based, whole-brain co-activation for each of the
structurally-identified ROIs. A MACM assessment aims
to identify, across a domain-arching pool of studies interrogating various mental operations and task paradigms,
brain areas that simultaneously co-activate with a userspecified seed region. In other words, a MACM assessment identifies brain areas most likely to be activated
across all tasks, given activation within a seed. Similar to
seed-based resting-state functional connectivity assessments of fMRI data, a MACM identifies those regions
that are significantly related to, and presumably interact with the seed. First, we identified experiments in the
database that reported one or more activation coordinates within a seed ROI using the Sleuth software application (http://www.brainmap.org/sleuth/). The seeds
were 8 mm radius spheres centered on the voxels with
maximum ALE values within each of the smoking-related
gray matter loss regions identified above. We conducted
separate searches and computed separate MACMs for
each of these ROIs. As practiced in previous MACM
assessments to achieve sufficient power [e.g., 56], only
those ROIs associated with 30 or more experiments in
the database were considered for further analyses. We
employed 8 mm radial spheres to equate each ROIs volume and to seek a balance between returning a sufficient
number of experiments from the database and minimizing overlap between ROIs that were in close proximity. Next, we extracted the whole-brain coordinates of
all foci that co-activated with the seed, constraining this
extraction to only activation foci (i.e., no deactivations)
reported in studies examining healthy participants (i.e.,
no intervention or group comparisons). After converting
foci reported in MNI to Talairach space [47], we supplied
these foci as input to the ALE methodology described
above thereby delineating regions of convergent co-activation with the seed when employing a cluster-corrected
threshold of pcorrected < 0.05 (voxel-level: p < 0.001). These
thresholded MACM maps for each ROI represent the
above-chance probability that identified voxels co-activated with the respective seed across many neuroimaging tasks. To determine whether smoking-related gray
matter loss regions reflected disruption of functionally
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interrelated neurocircuits, we quantified the degree to
which one ROI’s MACM map intersected with any of the
other structurally impacted ROIs. If one ROI’s MACM
map overlapped at least 50 voxels of any other ROI, those
two regions were considered to constitute a circuit-level
functional interaction.
In addition to the co-activation coordinates, we also
extracted the corresponding BrainMap metadata allowing for the generation of behavioral profiles for each pair
of co-activating, and presumably functionally-related,
ROIs. The metadata in the database are coded according
to a well-defined taxonomy (http://www.brainmap.org/
taxonomy/) cataloguing each contributing study’s experimental design, stimulus type, behavioral domain (and
subcategory), and paradigm class [57, 58]. Under this
taxonomy, behavioral domains (BD) represent the mental processes interrogated by the primary study’s statistical contrasts and comprise the main categories of action,
cognition, emotion, interoception, and perception as well
as BD subcategories (BD-S; e.g., perception: somesthesispain). Paradigm classes (PC) further categorize the specific task employed (e.g., pain monitoring/discrimination,
Go/No-Go). We used these metadata terms to delineate
behavioral phenomena linked with the concurrent activation of those pairs of structurally-identified ROIs considered to constitute circuit-level functional interactions in
the above MACM assessments.
Specifically, we created behavioral profiles for circuits of
interest by performing forward and reverse inference
analyses [34, 35] on the associated distribution of metadata terms [59, 60]. In the forward inference approach, we
tested whether the conditional probability of brain activation given a particular behavioral phenomenon (i.e., BD,
BD-S, or PC), p(Activation|Phenomenon), was higher
than the baseline probability of brain activation,
p(Activation). Baseline activation was defined as the probability of finding a random activation from the database in
the region(s) of interest. Significance was established with
a binomial test (pFDR-corrected < 0.05). In the reverse inference approach, we identified the most likely behavioral
phenomenon (i.e., BD, BD-S, or PC) given activation in a
region. This likelihood, p(Phenomenon|Activation), was
derived from p(Activation|Phenomenon) as well as
p(Phenomenon) and p(Activation) using Bayes’ Rule. Significance was established with a Chi-squared test
(pFDR-corrected < 0.05). Only BD, BD-S, and PC terms that
were significant in both the forward and reverse inference
approaches are reported.2
2

We note that these analyses represent an attempt to relate behavioral
phenomena with identified ROIs as opposed to claiming “a unique role” of
those ROIs with respect to behavior [34]. In other words, an association of
“behavioral phenomenon x to brain region y” obtained from these analyses
does not necessarily imply that activity in “region y is limited to behavioral
phenomenon x”.
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Results
Structural impact of chronic cigarette smoking

To elucidate structural alterations associated with an
extended smoking history, we conducted a meta-analysis identifying consistent gray matter decreases among
smokers. This meta-analysis included 78 distinct foci
from 14 peer-reviewed studies involving a total of 750
smokers and 1073 nonsmokers (Additional file 1: Table
S1). Across these studies, ALE revealed convergent gray
matter decreases in 12 distinct clusters, notably in the
ventromedial PFC (vmPFC), left insula, and mediodorsal (MD) thalamus, as well as in the medial orbitofrontal
cortex (mOFC), ventrolateral PFC (vlPFC), dorsomedial
PFC (dmPFC), medial PFC (mPFC), left parahippocampal gyrus, and right cerebellum (Fig. 1; Table 1).
Conjoint chronic smoking‑related structural effects
and acute drug‑induced functional effects

To delineate regions displaying both structural alterations
linked with chronic smoking and functional modulations
linked with acute nicotinic agonist administration, we
performed a multimodal assessment. Specifically, we conducted a conjunction analysis identifying regions showing
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both convergent: (1) smoking-related structural decreases
(Fig. 1), and (2) nAChR agonist-induced functional
decreases or increases [6]. This multimodal assessment
identified overlapping structural and functional effects
within the vmPFC, left insula, and MD thalamus (Fig. 2;
Table 2). Specifically, whereas gray matter decreases in
the vmPFC and insula overlapped with clusters of acute
drug-induced functional activity decreases (Fig. 2, green;
Additional file 1: Figure S2), gray matter decreases in MD
thalamus overlapped with drug-induced activity increases
(Fig. 2, orange; Additional file 1: Figure S3). We arrived
at similar outcomes and the same conclusions when performing this multimodal assessment when considering
only functional studies involving nicotine administration
(i.e., excluding other nAChR agonists; Additional file 1:
Figure S4) and when considering only functional results
involving cigarette smokers (Additional file 1: Figure S5).
Behavioral relevance of structurally impacted regions:
MACM and behavioral decoding

To enhance insight into the circuit-level consequences
of smoking-related structural alterations, we first performed a MACM assessment thereby identifying clusters

Fig. 1 Structural impact of chronic cigarette smoking. Convergent gray matter decreases among smokers (nonsmokers > smokers) were observed
notably in multiple PFC regions, the left insula, thalamus, and cerebellum. Numbering corresponds to coordinates listed in Table 1
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Table 1 Convergent gray matter decreases associated with chronic smoking: cluster coordinates
Cluster

Region

Volume

X

Y

Z

Nonsmokers > smokers
1

Thalamus (lateral posterior nucleus)

R

592

16

2

dmPFC (BA 6) (superior frontal gyrus)

R

576

16
−8

3

vmPFC (BA10) (superior frontal gyrus)

L

568

4

vlPFC (BA 10) (middle frontal gyrus)

R

480

5

dmPFC (BA 8) (medial frontal gyrus)

R

24

52

56

−4

32

46

480

10

40

−20

−34

6

Parahippocampal gyrus

L

432

7

mPFC (BA10) (medial frontal gyrus)

R

416

12

−20

Medial OFC (BA 11)

B

384

2

34

mPFC (BA10) (medial frontal gyrus)

L

376

58

10

Cerebellum (dentate)

R

368

−14

11

Insula (BA 13)

L

368

Thalamus (medial dorsal nucleus)

B

360

−40
2

0
8

8

12

4

36

58

9

14

14

−22

8

−58

−20

8

−18

10
4

3

Numbering corresponds to brain regions shown in Fig. 1. Coordinates (X, Y, Z) of the clusters’ peak voxels are reported in Talairach space. Volume is mm

B bilateral, R right, L left, BA Brodmann area, OFC orbitofrontal cortex, vmPFC ventromedial prefrontal cortex, vlPFC ventrolateral prefrontal cortex, dmPFC dorsomedial
prefrontal cortex, mPFC medial prefrontal cortex

Fig. 2 Conjoint structural and functional effects. Structural alterations (nonsmokers > smokers) overlapped with acute drug-induced activity
decreases (baseline > drug) in the insula and ventromedial PFC (green a, b). Structural alterations (nonsmokers > smokers) overlapped with acute
drug-induced activity increases (drug > baseline) in the mediodorsal thalamus (orange c). Lettering corresponds to coordinates listed in Table 2. See
Additional file 1: Figures S2 and S3 for visualization of overlapping and non-overlapping regions from the structural and functional meta-analyses

Table 2 Conjoint chronic smoking-related structural alterations and acute drug-induced functional activity changes:
cluster coordinates
Cluster

Region

Gray matter decreases ∩ functional decreases

Volume

X

−39

a

Insula (BA 13)

L

185

b

vmPFC (BA10) (superior frontal gyrus)

L

103

B

142

Gray matter decreases ∩ functional increases
c

Thalamus (medial dorsal nucleus)

Y

Z

7

9

−9

50

−3

2

−14

11

Lettering corresponds to brain regions shown in Fig. 2. Coordinates (X, Y, Z) of the clusters’ peak voxels are reported in Talairach space. Volume is mm3
B bilateral, R right, L left, BA Brodmann area, vmPFC ventromedial prefrontal cortex
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of convergent co-activation for each of the structurally
impacted ROIs. One region (mOFC) failed to return a
sufficient number of experiments from the BrainMap
database and was not considered further (Additional
file 1: Table S3). The remaining 11 whole-brain MACM
maps represent voxels with an above-chance probability
of co-activating with the seed when considering various neuroimaging tasks (Fig. 3; Additional file 1: Table
S4). For example, the MACM map for: (1) the vmPFC
seed (Fig. 3, ROI 3) indentified convergent co-activation
within the posterior cingulate cortex, dmPFC, parahippocampus, and inferior frontal gyrus, (2) the left insula
seed (Fig. 3, ROI 11) displayed notable co-activation
with the right insula, posterior medial prefrontal cortex
(encompassing the ACC and supplemental motor area),
the thalamus, parietal cortex, and cerebellum, and (3) the
MD thalamus seed (Fig. 3, ROI 12) encompassed the posterior medial PFC, bilateral insula, parietal cortex, and
cerebellar regions. These and similarly-derived MACM
maps delineating networks of task-based co-activation
resemble networks identified when considering taskindependent resting-state fMRI data [28, 61–64].
We then further assessed these co-activation maps
to determine whether structurally impacted regions
reflected functionally interrelated neurocircuits. Those
structurally impacted ROIs that also appeared to be
functionally related are summarized in Fig. 4a. In this
representation, the paths between regions indicate the
observation of one ROI intersecting with another ROI’s
MACM map. For example, the left insula’s MACM map
(Fig. 4a, ROI 11) overlapped the lateral posterior thalamus (ROI 1), cerebellum (ROI 10), and the MD thalamus
(ROI 12) and vice versa (represented by double-headed
arrows), whereas the left insula ROI was overlapped
by the MACM map derived for the vlPFC seed (ROI 4,
single-headed arrow). For the 11 ROIs, 12 unique paths
were identified (out of 55; Additional file 1: Figure S6)
representing pairs of regions with an above-chance probability of co-activation.
To characterize behavioral phenomena linked with
these pairs of functionally-related ROIs, we performed
behavioral decoding via forward and reverse inference
techniques on the associated BrainMap metadata terms
(BD, BD-S, and PC). Those behavioral phenomena significantly associated with co-activation of ROI pairs are
represented in Fig. 4b. We highlight four observations
from this assessment. First, the left insula’s co-activation
with multiple other ROIs was linked with aspects of pain
processing. Specifically, insula and vlPFC co-activation
(Fig. 4b, path: ROI 4–11) was significantly associated with
the BD perception (purple), the BD-S somesthesis-pain,
and the PC pain monitoring/discrimination. Similarly,
concurrent activation of the insula and MD thalamus
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(Fig. 4b, path: ROI 11–12) was linked with perception,
somesthesis-pain, and pain monitoring/discrimination
in addition to the PC recitation/repetition (overt). Insula
and lateral posterior thalamus co-activation (Fig. 4b,
path: ROI 11–1) was associated with perception and somesthesis-pain. Second, the right cerebellum’s co-activation
with multiple other ROIs was related to aspects of overt
body movements. Specifically, cerebellum and insula coactivation (Fig. 4b, path: ROI 10–11) was associated with
the BD action (red), the BD-S execution-speech, and the
PC recitation/repetition. Similarly, concurrent activation
of the cerebellum and MD thalamus (Fig. 4b, path: ROI
10–12) was related to action, execution (non-speech),
execution-speech, and recitation/repetition in addition to
the PCs of flexion/extension and Go/No-Go (i.e., inhibiting an overt body movement). Co-activation of the cerebellum and lateral posterior thalamus (Fig. 4b, path:
ROI 10–1) was linked with the BD action, BD-S execution (non-speech), and PC finger tapping/button press.
Third, co-activation of the parahippocampus and MD
thalamus (Fig. 4b, path: ROI 6–11) was related to the
BD cognition (green), the BD-S memory-explicit, and the
PCs cued-explicit and recognition/recall. Lastly, concurrent activation of the vmPFC and mPFC (Fig. 4b, path:
ROI 3–9) was associated with the PC face monitoring/
discrimination.

Discussion
We compiled structural MRI results to clarify the impact
of cigarette smoking on gray matter integrity. Our
meta-analytic results revealed convergent gray matter
decreases among smokers in multiple regions including the prefrontal cortex, insula, thalamus, and cerebellum. Given that such structural measures provide limited
insight into functional or behavioral implications, we
subsequently performed two additional meta-analytic
assessments to more fully contextualize these gray matter
decreases. Indicative of a structural–functional relation,
we observed via a multimodal assessment that chronic
smoking-related structural effects overlapped with the
acute functional effects of nAChR agonist administration
in the vmPFC, left insula, and MD thalamus. Suggestive
of structural-behavioral implications, we then identified
pairs of structurally impacted regions that tended to coactivate across various tasks and delineated behavioral
phenomena linked with such co-activation via MACM
and behavioral decoding, respectively. These assessments
linked the left insula’s co-activation with multiple other
brain regions to pain perception, the right cerebellum’s
co-activation with other regions to overt body movement, co-activation of the parahippocampus and MD
thalamus with memory processes, and co-activation of
medial PFC regions with face processing.
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Fig. 3 Meta-analytic connectivity modeling (MACM) maps of task-related co-activation for each structurally impacted ROI. These thresholded
MACM maps (pcorrected < 0.05) represent voxels with an above-chance probability of co-activating with the respective seed regions (8 mm radius
spheres centered on the voxels with maximum ALE values within each smoking-related gray matter loss region). One region (ROI 8; mOFC) failed
to return a sufficient number of contrasts from the database and was omitted from further analyses. Numbering corresponds to that in Table 1. The
seed ROI of each MACM map is outlined in red. MACM maps for ROIs boxed in red are discussed in the main text. See Additional file 1: Table S4 for
each seed ROI’s co-activation coordinates

Across studies, we observed convergent smokingrelated structural decreases in discrete brain regions
notably in the PFC (i.e., ventromedial, ventrolateral,

dorsomedial, orbitofrontal), insula, thalamus, and cerebellum. Although we can only speculate on the pathogenesis of such decreases, structural differences between
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Fig. 4 Pairs of functionally-related ROIs and associated behavioral phenomena. a Functionally-related ROIs are connected by paths, the directionality of which indicates that a given ROI (ending point, arrow head) intersected another ROIs MACM map (starting point). We note that if one ROI
overlapped another ROI’s MACM map, it did not necessarily indicate that the latter ROI overlapped with the former’s MACM map. See Additional
file 1: Figure S6 for an alternative representation. b Behavioral phenomena significantly associated with functionally-related ROIs were identified by
forward and reverse inference assessments of metadata terms. In this representation, significant behavioral domains (BD) are represented by path
color (perception [purple], action [red], cognition [green], no significant BD [gray]), significant behavioral domain subcategories (BD-S) are shown
along the path in bolded text, and significant paradigm classes (PC) are in standard text. Black paths indicate that no significant associations were
detected with any BD, BD-S, or PC

smokers and nonsmokers could be products of predisposing neurobiological risk factors [65], the deleterious
impact of cigarette smoking on microvascular functioning [66], neurotoxic events (e.g., oxidative stress, inflammation) associated with many of the >4000 compounds
present in tobacco smoke [67], and/or be mediated
directly or indirectly by nicotine itself. Focusing on the
last possibility, nAChRs are ubiquitous throughout the
human brain with particularly high densities in the thalamus, insula, and vmPFC [68, 69]. Widespread upregulation of nAChRs, likely related to receptor desensitization
from nicotine exposure, has been observed among smokers [70, 71] and, conversely, smoking cessation associated with decreases in regional nAChR densities [72].
Evidence from preclinical models suggests neurotoxic
events and protracted consequences on cholinergic
neurotransmission following nicotine exposure particularly during adolescence [73–75]. As such, one plausible
mechanistic account is that repeated stimulation of high
densities of nAChRs by nicotine may contribute to neurotoxicity within discrete regions and/or increase the vulnerability of those regions to other volatile compounds

in tobacco smoke [19] which ultimately manifest as gray
matter decreases.
Speaking to such an account, we conducted a multimodal meta-analytic assessment to determine if
smoking-related structural decreases overlapped with
nicotinic agonist-induced functional modulations and
observed conjoint effects in the vmPFC, insula, and
MD thalamus. In addition to possessing relatively high
nAChR densities, these regions also are critically implicated in addiction-related psychological processes. For
example, the vmPFC, in concert with other regions such
as the OFC and striatum, is thought to play a role in representing subjective value information, behavioral choice
selection, and evaluating outcomes and alterative rewards
[76–78]. The insula, a functionally heterogeneous region,
is involved with monitoring the physiological state of the
body, appears causally related to the initiation, maintenance, and adjustment of attentional control, and likely
plays a role in maladaptive decision-making among drug
addicts [79–82]. Dysfunction of the MD thalamus, a
primary node within a thalamic-PFC-basal ganglia network involved in associative learning, is implicated in the
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transition from goal-directed action (e.g., recreational
drug use) to habitual forms of responding (e.g., dysregulated drug seeking) [83, 84]. Consistent with the notion
that structural alterations in these regions are a product of prolonged nicotine/tobacco exposure, group differences between smokers and nonsmokers within, for
example, the insula were not detected among an adolescent/young adult participant sample with relatively lower
exposure levels (0.9 ± 0.7 pack-years on average) [85]
but were observed among similarly aged individuals with
relatively higher exposure levels (4.0 ± 1.8 pack-years)
[86]. Furthermore, multiple studies have provided evidence for dose-dependent exposure effects on gray matter integrity within the insula [18, 85] and vmPFC [19, 22,
86] as well as within the lateral PFC [14, 20] and cerebellum [23]. Widespread dose-dependent negative relations
between pack-years and cortical thickness were recently
corroborated in a large sample of older adults (N > 500)
with particularly robust effects in the medial and lateral
PFC [87]. Interestingly, positive relations between number of years since last cigarette and cortical thickness,
suggesting potential recovery with smoking cessation,
were also detected in medial PFC and posterior insula
regions, amongst others [87]. Our multimodal metaanalytic outcomes add to a growing literature implicating
the vmPFC, insula, and thalamus as contributors to the
initiation, escalation, maintenance, and/or cessation of
cigarette smoking.
Representing one objective approach for providing
insight into the behavioral relevance of convergent gray
matter decreases among smokers, we utilized emergent
meta-analytic tools to delineate structurally impacted
ROIs that tended to co-activate and their associated
behavioral phenomena. Similar approaches have been
used to quantitatively aid interpretation of regions identified via structural assessments or networks commonly
observed via resting-state fMRI (i.e., assessments inherently lacking direct behavioral insight) [28, 33]. Although
we adopted a quantitative approach to infer behavioral
relevance of structural alterations, we note that our interpretations remain largely speculative until experimentally
verified. We observed that co-activation of the left insula
with thalamic and lateral PFC regions were generally
linked with pain perception. Dysregulated pain processing is increasingly recognized as a potential barrier to
smoking cessation [88, 89] and emerging evidence suggests bidirectional relations between pain and smoking
behaviors [90, 91]. In laboratory assessments (e.g., cold
pressor test), minimally-deprived or abstinent smokers,
compared with nonsmokers, exhibit lower pain tolerance
and report greater subjective experiences of pain where
such pain reports positively correlate with nicotine withdrawal severity [92–94]. As such, nicotine abstinence
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may contribute to enhanced pain sensitivity that could
maintain cigarette smoking via negative reinforcement
mechanisms similar to other withdrawal symptoms [95].
Although the insula’s role in interoceptive monitoring has
been well characterized [80] and higher nAChR availability in the thalamus, PFC, and cerebellum has been positively correlated with increased pain sensitivity among
abstinent smokers [96], relatively little neuroimaging
work has focused on the neurobiological processes that
may contribute to smoking- or withdrawal-related pain
dysregulation. Our meta-analytic outcomes suggest that
neuroimaging investigations of pain perception among
smokers, with emphasis on the putative functional interactions between the insula and MD thalamus, may be a
productive avenue for future research.
We also observed that co-activation of the right cerebellum with insula and thalamic regions were generally
linked with overt body movements. Acutely administered, nicotine augments performance in simple motor
tasks [9] and increases cerebellar vermis activity during
externally paced finger tapping [97]. On the other hand,
chronic cigarette smokers perform worse than nonsmokers on neurocognitive measures of fine motor skills and
postural stability [11]. Smoking-related decreases in
right cerebellum gray matter, identified via an ROI-based
approach [16] (i.e., a study not meeting inclusion criteria for the current meta-analysis), further corroborate
our observation of convergent decreases in this region.
Whereas our outcomes are consistent with the cerebellum’s critical role in motor coordination, they also align
with contemporary views emphasizing the region’s contribution to cognitive processes [98, 99] and relevance
to drug addiction [100, 101]. For example, we observed
that co-activation of the cerebellum and MD thalamus
was significantly associated with Go/No-Go paradigms
that require inhibitory control. Although current neurobiological models of addiction have yet to provide an
integrative account of this region’s contribution, altered
cerebellar structure and function appears to be a common characteristic across drugs of abuse [100]. Our
meta-analytic outcomes serve to further draw attention
to the cerebellum in the context of addiction in general
and cigarette smoking in particular.
Lastly, co-activation of the parahippocampus and MD
thalamus was linked with memory processes and co-activation of medial PFC regions linked with face processing. Regarding the former observation, neurocognitive
assessments have consistently identified visuospatial
learning and memory deficits among older (>60 years)
as well as middle-aged smokers (30–60 years) relative to
nonsmokers [11, 12]. Regarding the latter observation,
as face processing paradigms often directly or indirectly
involve affective components, a plausible interpretation
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is that smoking-related structural effects in medial PFC
regions may relate to disrupted emotional processing
and/or regulation [102, 103]. Indeed, smokers tend to
report elevated negative mood and a reduced ability to
self-regulate such states when compared with nonsmokers [104, 105].
Our findings should be considered in light of remaining issues. First, the ALE framework is a coordinatebased meta-analytic approach that does not incorporate
the size of identified clusters from the primary studies,
which leads to less precise representations relative to
image-based approaches [106], which, on the other hand,
are themselves often less feasible. Second, we only considered gray matter decreases among smokers owing to a
small number of reported experiments/foci in the literature with respect to increases. Nonetheless, neuroimaging studies have documented smoking-related volumetric
increases in the caudate and putamen [17, 86], positive
correlations between putamen volume and lifetime nicotine/tobacco exposure [107], and positive correlations
between greater striatal volume and more intense cueinduced tobacco craving [108]. Third, we followed previous recommendations that at least 10-15 experiments
should be included in an ALE meta-analysis and note
that the meta-analysis identifying gray matter decreases
among smokers involved 14 studies. Based on recent data
simulations [43], closer to ~20 experiments has been prescribed to achieve sufficient power to detect moderately
sized effects. Fourth, meta-analytic results are limited by
the methodology commonly employed by the included
studies. With respect to the use of T1-weighted MRIs to
assess gray matter, we note recent commentaries regarding the potential for drug-induced cerebral blood flow
alterations to complicate interpretation of structural
outcomes [109, 110]. Given that many studies included
in this meta-analysis did not report the time elapsed
between last cigarette smoked and MRI data collection
(Additional file 1: Table S2), this potential confounding
factor cannot be ruled out. Fifth, our behavioral decoding outcomes are limited by the studies archived in the
BrainMap database at the time of analysis as well as its
associated taxonomy. Sixth, although some studies have
begun to characterize the impact of smoking on gray
matter in young adult/adolescent smokers [85, 86], the
concurrent influence of marijuana [111] or alcohol use
[112], and sex differences among smokers [17], as more
studies accumulate regarding the influence of these and
other important factors on gray matter alterations, it
will become possible to better characterize the specificity of the meta-analytic effects identified herein. Lastly, it
remains for future work, perhaps through multi-site longitudinal investigations, to determine whether regional
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structural alterations are a cause or consequence of cigarette smoking (or a combination thereof ) and the extent
to which such alterations recover following cessation.
In sum, cigarette smoking was associated with convergent structural decreases across studies in the PFC,
insula, thalamus, and cerebellum. Some of these chronic
smoking-related structural effects overlapped with
regions showing acute nicotinic drug-induced functional
effects. This study highlights the utility of using neuroimaging meta-analytic techniques to compile, synthesize, and inform neuroimaging investigations aiming to
elucidate the neurobiological factors underlying the initiation, escalation, maintenance, and/or cessation of cigarette smoking. Collectively, our findings emphasize brain
regions (e.g., vmPFC, insula, thalamus) and circuits (e.g.,
insula-thalamus) linked with chronic smoking, suggest
neuroimaging paradigms warranting additional consideration among smokers (e.g., pain processing), and point to
regions in need of further elucidation in addiction (e.g.,
cerebellum).

Additional file
Additional file 1. Supplementary tables and figures.
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